Mouse Anti-ITLN1 Recombinant Antibody (A702) (CBMAB-AP4044LY)

Nonnecke, E. B., Castillo, P. A., Akahoshi, D. T., Goley, S. M., Bevins, C. L., & Lönnerdal, B. (2022). Characterization of an intelectin-1 (Itln1) knockout mouse model. Frontiers in Immunology, 13, 894649.

Nonnecke, E. B., Castillo, P. A., Dugan, A. E., Almalki, F., Underwood, M. A., De La Motte, C. A., ... & Bevins, C. L. (2021). Human intelectin-1 (ITLN1) genetic variation and intestinal expression. Scientific reports, 11(1), 12889.

Chen, L., Jin, X. H., Luo, J., Duan, J. L., Cai, M. Y., Chen, J. W., ... & Xie, D. (2021). ITLN1 inhibits tumor neovascularization and myeloid derived suppressor cells accumulation in colorectal carcinoma. Oncogene, 40(40), 5925-5937.

Au-Yeung, C. L., Yeung, T. L., Achreja, A., Zhao, H., Yip, K. P., Kwan, S. Y., ... & Mok, S. C. (2020). ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment. Nature communications, 11(1), 3546.

Hamdy, N. M., & El-Shemy, R. A. (2020). Molecular Profiling of Breast Cancer Susceptibility of Obese or Insulin-Resistant and Pre-Diabetic Patients Using ITLN1 and CD295 SNPs. medRxiv, 2020-01.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols